Hilar Cholangiocarcinoma

Authors:

Abstract
Hilar cholangiocarcinoma, sometimes referred to as a Klatskin tumor, is a rare neoplasm arising proximal to the confluence of the cystic and common hepatic ducts.1,2 In the United States, hilar cholangiocarcinoma has a reported annual incidence of 1 to 2 persons per 100 000 population.3,4 Although a subset of patients may have a hilar tumor characterized as slow growing and late to metastasize,1,2 most patients with untreated cholangiocarcinoma have a median survival of 6 months.5,6 Although surgical resection is the only curative option, 5-year survival following resection of hilar cholangiocarcinoma has been reported to range from 20% to 40%.7-10

This publication has 30 references indexed in Scilit: